St. Jude Medical Inc (STJ.N)
47.00USD
17 May 2013
$0.18 (+0.38%)
$46.82
$46.84
$47.15
$46.70
775,188
685,835
$47.15
$30.25
STJ.N
About
Overall
| Beta: | 0.87 |
| Market Cap (Mil.): | $13,318.05 |
| Shares Outstanding (Mil.): | 283.36 |
| Dividend: | 0.25 |
| Yield (%): | 2.13 |
Financials
European, US retailers split on Bangladesh reform plan
STOCKHOLM/CHICAGO - Major U.S. retailers, including Gap Inc , declined to endorse an accord on Bangladesh building and fire safety backed by Europe's two biggest fashion chains, a trans-Atlantic divide that may dilute garment industry reform efforts.
H&M, others back new Bangladesh factory safety accord
STOCKHOLM/MADRID - The world's two biggest fashion retailers, Inditex and H&M , along with several other companies have backed an accord aimed at preventing another disaster like last month's Bangladesh factory building collapse that killed more than 1,100 people.
UPDATE 1-STMicroelectronics posts loss as ST-Ericsson weighs
SAN FRANCISCO, April 22 - European chipmaker STMicroelectronics posted its sixth straight quarterly loss, hurt by costs linked to the closure of joint venture ST-Ericsson and weak European semiconductor demand.
St. Jude Medical profit tops view, forex to hurt revenue
- Medical device maker St. Jude Medical Inc said on Wednesday first-quarter profit rose as lower expenses outweighed a decline in sales but warned that full-year revenue will be hurt by foreign exchange effects.
UPDATE 2-St. Jude Medical profit tops view, forex to hurt revs
April 17 - Medical device maker St. Jude Medical Inc said on Wednesday first-quarter profit rose as lower expenses outweighed a decline in sales but warned that full-year revenue will be hurt by foreign exchange effects.
St. Jude Medical post higher quarterly profit
April 17 - St. Jude Medical Inc said on Wednesday its quarterly earnings rose as expenses fell.
St. Jude wins European OK for brain implant to treat Dystonia
April 10 - St. Jude Medical Inc on Wednesday said it received European regulatory approval for its brain implant used to treat primary and secondary Dystonia, a neurological movement disorder.
Fitch Rates St. Jude Medical's Notes Offering 'A'; Outlook Stable
(The following statement was released by the rating agency) CHICAGO, March 21 (Fitch) Fitch Ratings has assigned an 'A' rating to St. Jude Medical, Inc.'s (STJ) notes offering. The company intends to use the net proceeds of this offering for general corporate purposes, which may include the repayment of certain indebtedness. The Rating Outlook is Stable, and the ratings apply to approximately $3.06 billion of debt outstanding as of Dec. 31, 2012. A full list of STJ's ratings is available a
St Jude Medical's device to prevent stroke misses study goal
- A clinical trial evaluating St. Jude Medical Inc's implantable device used to prevent stroke in patients who have a common congenital heart defect failed to achieve its main goal.
St Jude Medical's device to prevent stroke misses study goal
March 20 - A clinical trial evaluating St. Jude Medical Inc's implantable device used to prevent stroke in patients who have a common congenital heart defect failed to achieve its main goal.
Competitors
| Price | Change | |
|---|---|---|
| Medtronic, Inc. (MDT.N) | $49.84 | +0.20 |
| Boston Scientific Corporation (BSX.N) | $9.10 | +0.06 |
| Abbott Laboratories (ABT.N) | $36.59 | -0.24 |
| Edwards Lifesciences Corp (EW.N) | $67.06 | -1.55 |
| Johnson & Johnson (JNJ.N) | $88.09 | +0.64 |
| Cyberonics, Inc. (CYBX.OQ) | $49.27 | +1.05 |
| Volcano Corporation (VOLC.OQ) | $16.63 | +0.05 |
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
